|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Atricure Inc (ATRC)
CHAIKIN MONEY FLOW
Trading: HOLD @ $40
Signal Strength: MEDIUM
Atricure Inc (NASDAQ:ATRC) current price has highlighted recent buying pressure and the continuation of a bullish trading conditions. Currently, the CMF is 0.26. ATRC received a confirmed CMF crossover days on the Oct 25 2019. The bullish signal has been active for 0 day. During the quarter, the highest CMF value was 0.56 occurring on the Oct 25 2019.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Developed by Marc Chaikin, Chaikin Money Flow measures the amount of Money Flow Volume over a specific period. Money Flow Volume forms the basis for the Accumulation Distribution Line. Instead of a cumulative total of Money Flow Volume, Chaikin Money Flow simply sums Money Flow Volume for a specific look-back period, typically 20 or 21 days. The resulting indicator fluctuates above/below the zero line just like an oscillator. Chartists weigh the balance of buying or selling pressure with the absolute level of Chaikin Money Flow. Chartists can also look for crosses above or below the zero line to identify changes on money flow.
Calculation: Chaikin Money Flow (20):
1) Money Flow Multiplier = [(Close - Low) - (High - Close)] / (High - Low);
2) Money Flow Volume = Money Flow Multiplier x Volume for the Period;
3) 20-period CMF = 20-period Sum of Money Flow Volume / 20 period Sum of Volume;
PROFILE: Atricure Inc (ATRC)
Stock Exchange: NASDAQ
Company: Atricure Inc
Ticker Codes: | ATRC | NASDAQ:ATRC |
AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy; and EPi-Sense guided coagulation system used for the temporary cardiac signal sensing and recording during surgery. It also provides SUBTLE cannula, an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach; multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable physicians to create an expanded cardiac ablation lesion set. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; and CryoICE CRYO2 cryoablation system to apply cryo-energy to targeted intercostal peripheral nerves in the ribcage and temporarily relieve pain. Further, it provides Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; Fusion Magnetic Retriever System that allows access around anatomical structures; and cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. AtriCure sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.
|NVAX Novavax Inc||11.8||28.1||27,140,609||0.46||BULLISH|
|STKL Sunopta Inc||2.69||13||767,118||0.27||BULLISH|
|ECPG Encore Capital||34.61||12||1,185,057||0.06||BULLISH|
|INO Inovio Pharma||4.36||9.3||34,675,337||0.39||BULLISH|
|BCRX BioCryst Pharmaceuticals||2.74||8.3||11,180,169||0.2||BULLISH|
|STAA Staar Surgical||31.05||8||1,662,302||0.17||BULLISH|
|KPTI Karyopharm Therapeutics||15.38||7||1,860,063||0.23||BULLISH|
|DLTH Duluth Holdings||7.39||5.1||226,062||0.16||BULLISH|